PE20140200A1 - Metodo para producir y usar un copolimero de carboximetilcelulosa sodica y gosipol - Google Patents
Metodo para producir y usar un copolimero de carboximetilcelulosa sodica y gosipolInfo
- Publication number
- PE20140200A1 PE20140200A1 PE2013000829A PE2013000829A PE20140200A1 PE 20140200 A1 PE20140200 A1 PE 20140200A1 PE 2013000829 A PE2013000829 A PE 2013000829A PE 2013000829 A PE2013000829 A PE 2013000829A PE 20140200 A1 PE20140200 A1 PE 20140200A1
- Authority
- PE
- Peru
- Prior art keywords
- sodium
- gosipol
- weight
- carboximethyl
- carboximethylcellulose
- Prior art date
Links
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title abstract 3
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 title abstract 3
- 229950005277 gossypol Drugs 0.000 title abstract 3
- 239000011734 sodium Substances 0.000 title abstract 3
- 229910052708 sodium Inorganic materials 0.000 title abstract 3
- 229920001577 copolymer Polymers 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 229920002678 cellulose Polymers 0.000 abstract 2
- 239000001913 cellulose Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- 239000012670 alkaline solution Substances 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract 1
- 239000001569 carbon dioxide Substances 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/02—Alkyl or cycloalkyl ethers
- C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
- C08B11/10—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
- C08B11/12—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals substituted with carboxylic radicals, e.g. carboxymethylcellulose [CMC]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
- C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
METODO DE PRODUCCION DE UN COPOLIMERO DE CARBOXIMETILCELULOSA SODICA CON UN GRADO DE SUSTITUCION DE 0,35 A 0,80 Y GOSIPOL, DE FORMULA 1, DONDE: a ES 1; b ES 3 A 6; c ES 5 A 7; n ES 40 A 50; CON UN PESO MOLECULAR DE 120.000-130.000. DICHO METODO COMPRENDE HACER REACCIONAR UNA DISOLUCION ACUOSA DE CARBOXIMETILCELULOSA SODICA CON UNA DISOLUCION ACUOSA DE ACIDO PERYODICO O PERYODATO DE SODIO MIENTRAS SE HACE PASAR DIOXIDO DE CARBONO HASTA ALCANZAR UN pH de 3,0 A 4,5, AISLAR DIALDEHIDO-CARBOXIMETILCELULOSA, TRATAR EL PRODUCTO RESULTANTE CON GOSIPOL O ACIDO ACETICO-GOSIPOL Y LUEGO CON UNA DISOLUCION ALCALINA ACUOSA, AISLAR EL PRODUCTO MEDIANTE PRECIPITACION CON UN DISOLVENTE ORGANICO. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: a) 10% A 16% EN PESO DE PRINCIPIO ACTIVO DE FORMULA 1, b) 10% A 20 % EN PESO DE ALIMIDON, c) 0.6% A 0.8% EN PESO DE ESTEARATO DE CALCIO O MAGNESIO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010141697/05A RU2453559C1 (ru) | 2010-10-11 | 2010-10-11 | Способ получения сополимера натрийкарбоксиметилцеллюлозы и госсипола и его применение в комплексной терапии пациентов с аутистическими расстройствами и когнитивными нарушениями |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20140200A1 true PE20140200A1 (es) | 2014-02-21 |
Family
ID=45938511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2013000829A PE20140200A1 (es) | 2010-10-11 | 2011-10-06 | Metodo para producir y usar un copolimero de carboximetilcelulosa sodica y gosipol |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US9078916B2 (es) |
| EP (1) | EP2628754B8 (es) |
| JP (1) | JP5690944B2 (es) |
| CN (1) | CN103189393B (es) |
| AU (1) | AU2011314406B2 (es) |
| BR (1) | BR112013008888B1 (es) |
| CA (2) | CA2896450A1 (es) |
| CL (2) | CL2013000962A1 (es) |
| CO (1) | CO6731081A2 (es) |
| CY (1) | CY1119413T1 (es) |
| DK (1) | DK2628754T3 (es) |
| EA (2) | EA024810B1 (es) |
| EC (1) | ECSP13012613A (es) |
| ES (1) | ES2643167T3 (es) |
| GE (1) | GEP201706607B (es) |
| HR (1) | HRP20171330T1 (es) |
| HU (1) | HUE034920T2 (es) |
| LT (1) | LT2628754T (es) |
| PE (1) | PE20140200A1 (es) |
| PL (1) | PL2628754T3 (es) |
| PT (1) | PT2628754T (es) |
| RS (1) | RS56257B1 (es) |
| RU (1) | RU2453559C1 (es) |
| SI (1) | SI2628754T1 (es) |
| SM (1) | SMT201700497T1 (es) |
| UA (2) | UA108126C2 (es) |
| WO (1) | WO2012050483A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2499002C1 (ru) * | 2012-06-14 | 2013-11-20 | Общество С Ограниченной Ответственностью "Ниармедик Плюс" | Конъюгаты госсипола и натрийкарбоксиметилцеллюлозы, способы их получения и противовирусные средства на их основе |
| RU2577539C2 (ru) * | 2014-06-17 | 2016-03-20 | Общество С Ограниченной Ответственностью "Ниармедик Плюс" | Полимерные производные госсипола, способ их получения и фармацевтическая композиция на их основе |
| RU2754067C2 (ru) * | 2018-05-18 | 2021-08-25 | Общество с ограниченной ответственностью "НИАРМЕДИК ФАРМА" | Противомикробная композиция на основе полифенолов и полисахаридов, способ ее получения и применение |
| RU2746504C1 (ru) * | 2020-02-27 | 2021-04-14 | Ниармедик Интернэшнл Лимитед | Противомикробные средства на основе бета-глюканов, способы их получения и применения |
| CN114622407B (zh) * | 2022-04-01 | 2023-09-19 | 浙江隆腾医用新材料有限公司 | 一种羧甲基纤维素钠纤维的洗脱方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2002755C1 (ru) * | 1991-02-04 | 1993-11-15 | Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи РАМН | Производное целлюлозы и госсипола, обладающее интерферониндуцирующим и противовирусным действием |
| RU2222548C2 (ru) * | 2000-07-21 | 2004-01-27 | Зао "Ниармедик Плюс" | Применение производного целлюлозы и госсипола в качестве радиопротекторного, противоинфекционного и потенциирующего средства, усовершенствованный способ его получения и фармацевтическая композиция на его основе |
| KR20050013125A (ko) * | 2002-06-10 | 2005-02-02 | 와이어쓰 | Ｏ-데스메틸-벤라팍신의 신규한 포르메이트 염 |
| DE10226494A1 (de) * | 2002-06-14 | 2004-01-08 | Lts Lohmann Therapie-Systeme Ag | Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen |
| RU2238122C1 (ru) * | 2003-01-20 | 2004-10-20 | Ооо "Ниармедик Плюс" | Противоинфекционный фармацевтический препарат |
| RU2270708C1 (ru) * | 2004-05-26 | 2006-02-27 | Ооо "Ниармедик Плюс" | Натриевая соль сополимера карбоксиметилцеллюлозы и госсипола, фармацевтическая композиция и способ профилактики или лечения вирусных заболеваний |
| US20060144723A1 (en) * | 2004-11-02 | 2006-07-06 | Mary Fuller | Device for securing valuables |
| CA2613631A1 (en) * | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Improved dosage forms for movement disorder treatment |
| US20090285865A1 (en) * | 2008-05-14 | 2009-11-19 | Shalaby Shalaby W | Palatable, solid oral formulations for male chemical sterilization |
-
2010
- 2010-10-11 RU RU2010141697/05A patent/RU2453559C1/ru active
-
2011
- 2011-06-10 UA UAA201305876A patent/UA108126C2/ru unknown
- 2011-10-06 PL PL11832823T patent/PL2628754T3/pl unknown
- 2011-10-06 LT LTEP11832823.6T patent/LT2628754T/lt unknown
- 2011-10-06 SM SM20170497T patent/SMT201700497T1/it unknown
- 2011-10-06 CA CA2896450A patent/CA2896450A1/en not_active Abandoned
- 2011-10-06 SI SI201131286T patent/SI2628754T1/en unknown
- 2011-10-06 HU HUE11832823A patent/HUE034920T2/en unknown
- 2011-10-06 CN CN201180048898.4A patent/CN103189393B/zh not_active Expired - Fee Related
- 2011-10-06 WO PCT/RU2011/000785 patent/WO2012050483A1/ru not_active Ceased
- 2011-10-06 EA EA201390530A patent/EA024810B1/ru active IP Right Revival
- 2011-10-06 DK DK11832823.6T patent/DK2628754T3/da active
- 2011-10-06 BR BR112013008888-5A patent/BR112013008888B1/pt not_active IP Right Cessation
- 2011-10-06 UA UAA201411350A patent/UA108975C2/ru unknown
- 2011-10-06 CA CA2811583A patent/CA2811583C/en not_active Expired - Fee Related
- 2011-10-06 JP JP2013533814A patent/JP5690944B2/ja not_active Expired - Fee Related
- 2011-10-06 AU AU2011314406A patent/AU2011314406B2/en not_active Ceased
- 2011-10-06 GE GEAP201113083A patent/GEP201706607B/en unknown
- 2011-10-06 EP EP11832823.6A patent/EP2628754B8/en active Active
- 2011-10-06 ES ES11832823.6T patent/ES2643167T3/es active Active
- 2011-10-06 EA EA201690544A patent/EA031316B1/ru active IP Right Revival
- 2011-10-06 US US13/877,416 patent/US9078916B2/en not_active Expired - Fee Related
- 2011-10-06 RS RS20170877A patent/RS56257B1/sr unknown
- 2011-10-06 PT PT118328236T patent/PT2628754T/pt unknown
- 2011-10-06 HR HRP20171330TT patent/HRP20171330T1/hr unknown
- 2011-10-06 PE PE2013000829A patent/PE20140200A1/es active IP Right Grant
-
2013
- 2013-04-10 CL CL2013000962A patent/CL2013000962A1/es unknown
- 2013-05-09 EC ECSP13012613 patent/ECSP13012613A/es unknown
- 2013-05-10 CO CO13117014A patent/CO6731081A2/es unknown
-
2015
- 2015-05-05 CL CL2015001180A patent/CL2015001180A1/es unknown
-
2017
- 2017-09-14 CY CY20171100974T patent/CY1119413T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY156938A (en) | Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application | |
| PE20140200A1 (es) | Metodo para producir y usar un copolimero de carboximetilcelulosa sodica y gosipol | |
| MX2020005956A (es) | Sales organicas de acido sulfonico de esteres de aminoacidos y proceso para su preparacion. | |
| MY158663A (en) | Fermentation broth formulations | |
| EA201591639A1 (ru) | Обработка гидроксикарбоновых кислот с получением полимеров | |
| MY183859A (en) | Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate | |
| PH12013500472A1 (en) | Piperidinyl-substituted lactams as gpr119 modulators | |
| UA105229C2 (uk) | Фармацевтичний склад | |
| NZ603762A (en) | Production of soluble protein solutions from pulses | |
| BR112013000920A2 (pt) | compostos para a redução de produção de beta-amiloide | |
| AU2013328639A8 (en) | Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture | |
| BR112012028766A2 (pt) | processo para a preparação de complexos de insulina e zinco | |
| BR112013000282A2 (pt) | derivados do ácido (2-arilóxi-acetilamino)-fenil-propiônico, método para produzir o mesmo e a utilização dos mesmos como produtos farmacêuticos | |
| MX2010008051A (es) | Nuevos derivados de fluoroglicosidos aromaticos, productos farmaceuticos que comprenden dichos compuestos y uso de los mismos. | |
| MX383551B (es) | Derivados de glutarimida, uso de los mismos, composicion farmaceutica basada en los mismos y metodos para producir derivados de glutarimida | |
| CY1115590T1 (el) | Σουλφοξιμινυποκατεστημενα παραγωγα ανιλινοπυριμιδινης ως cdk-αναστολεις, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα | |
| NZ593787A (en) | Lyophilised dabigatran | |
| NZ602450A (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
| AR088963A1 (es) | Complejo obtenido a partir de mezclas de acido hialuronico o una sal del mismo y sulfato de condroitina | |
| BR112013018298A2 (pt) | compostos para a redução da produção de beta-amiloides | |
| AR082965A1 (es) | Metodo de preparacion de amidas de acido hialuronico altamente sustituidas | |
| MX2013003581A (es) | Proceso para producir granulos que comprende una o mas sales de agentes complejas. | |
| GEP20156312B (en) | Improved process for preparing soluble granules of salts of pyridine – carboxylic acids | |
| RU2008117550A (ru) | Модификация альбумина совиалем как способ повышения его стабильности для производства фармацевтического биопрепарата альбумина в комплексе с гентамицином или стимаденом | |
| PE20121481A1 (es) | Formulacion de liberacion sostenida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |